Phase II Trial of Ontak With Metastatic Melanoma

This study has been completed.

Study NCT00299689 Information provided by James Graham Brown Cancer Center

First Received: March 3, 2006 Last Updated: September 21, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	January 2010
Primary Completion Date:	January 2010 (Final data collection date for primary outcome measure)

No publications provided by James Graham Brown Cancer Center

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Rasku MA, Clem AL, Telang S, Taft B, Gettings K, Gragg H, Cramer D, Lear SC, McMasters KM, Miller DM, Chesney J. Transient T cell depletion causes regression of melanoma metastases. J Transl Med. 2008 Mar 11;6:12.